ERTUGLIFLOZIN AND METFORMIN HYDROCHLORIDE

ERTUGLIFLOZIN AND METFORMIN HYDROCHLORIDE was reported 82 times

ERTUGLIFLOZIN AND METFORMIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 KUSSMAUL RESPIRATION 1 0.0048
1 RELAPSING FEVER 1 0.0035
2 VULVOVAGINITIS 1 0.0034
3 GASTRIC HYPOMOTILITY 1 0.0033
4 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 2 0.0017
5 NEUROENDOCRINE CARCINOMA 1 0.0014
6 MUSCLE DISCOMFORT 1 0.0013
7 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
8 PHARYNGEAL INFLAMMATION 1 0.0008
9 INJECTION SITE OEDEMA 1 0.0006
10 EPIGASTRIC DISCOMFORT 2 0.0005
11 APPLICATION SITE SCAB 1 0.0005
12 INJECTION SITE INDENTATION 1 0.0005
13 URINARY HESITATION 1 0.0004
14 WEIGHT ABNORMAL 1 0.0004
15 INABILITY TO AFFORD MEDICATION 4 0.0004
16 TOE AMPUTATION 2 0.0004
17 HERNIA REPAIR 1 0.0004
18 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
19 DIABETIC KETOACIDOSIS 6 0.0002
20 CYSTITIS HAEMORRHAGIC 1 0.0002
21 MUSCLE FATIGUE 1 0.0002
22 TONGUE DISCOMFORT 1 0.0002
23 INJECTION SITE INFLAMMATION 1 0.0002
24 DYSPHORIA 1 0.0002
25 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
26 ASPIRATION 2 0.0002
27 BLOOD GLUCOSE FLUCTUATION 2 0.0002
28 PERIORBITAL SWELLING 1 0.0002
29 HYPOVOLAEMIA 1 0.0002
30 TYPE 1 DIABETES MELLITUS 1 0.0002
31 CARDIAC FLUTTER 1 0.0002
32 KETOACIDOSIS 1 0.0001
33 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
34 VAGINAL DISCHARGE 1 0.0001
35 RENAL PAIN 1 0.0001
36 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
37 APPLICATION SITE IRRITATION 1 0.0001
38 INJECTION SITE DISCOLOURATION 1 0.0001
39 IMPAIRED GASTRIC EMPTYING 1 0.0001
40 DEVICE MECHANICAL ISSUE 1 0.0001
41 HYPERTHYROIDISM 1 0.0001
42 BLOOD COUNT ABNORMAL 1 0.0001
43 INSURANCE ISSUE 1 0.0001
44 LACTIC ACIDOSIS 2 0.0001
45 FUNGAL INFECTION 2 0.0001
46 ORTHOSTATIC HYPOTENSION 1 0.0001
47 METASTASES TO LIVER 1 0.0001
48 BLOOD GLUCOSE ABNORMAL 1 0.0001
49 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
50 PRODUCT DOSE OMISSION 3 0.0000
51 APPLICATION SITE PAIN 1 0.0000
52 NO ADVERSE EVENT 8 0.0000
53 HYPOPHAGIA 1 0.0000
54 ERECTILE DYSFUNCTION 1 0.0000
55 EXPOSURE VIA SKIN CONTACT 1 0.0000
56 APPLICATION SITE ERYTHEMA 1 0.0000
57 PRODUCT DOSE OMISSION ISSUE 11 0.0000
58 MOOD ALTERED 1 0.0000
59 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
60 ACUTE MYOCARDIAL INFARCTION 1 0.0000
61 LACRIMATION INCREASED 1 0.0000
62 CYSTITIS 1 0.0000
63 RESTLESSNESS 1 0.0000
64 DYSURIA 1 0.0000
65 INFLUENZA 3 0.0000
66 ROAD TRAFFIC ACCIDENT 1 0.0000
67 DEVICE LEAKAGE 1 0.0000
68 VAGINAL HAEMORRHAGE 1 0.0000
69 INTENTIONAL PRODUCT MISUSE 2 0.0000
70 THROAT IRRITATION 1 0.0000
71 ADVERSE EVENT 2 0.0000
72 FLUID RETENTION 1 0.0000
73 THERAPY CESSATION 1 0.0000
74 ABDOMINAL DISTENSION 2 0.0000
75 ECZEMA 1 0.0000
76 ANAPHYLACTIC REACTION 1 0.0000
77 FLATULENCE 1 0.0000
78 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
79 IRRITABILITY 1 0.0000
80 VISUAL IMPAIRMENT 2 0.0000
81 PRODUCT USE ISSUE 3 0.0000
82 BLOOD GLUCOSE INCREASED 3 0.0000
83 DEEP VEIN THROMBOSIS 1 0.0000
84 BLOOD CREATININE INCREASED 1 0.0000
85 INJECTION SITE REACTION 1 0.0000
86 AGITATION 1 0.0000
87 ASTHENIA 5 0.0000
88 DECREASED APPETITE 3 0.0000
89 VOMITING 6 0.0000
90 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
91 DRY MOUTH 1 0.0000
92 RENAL IMPAIRMENT 1 0.0000
93 URINARY TRACT INFECTION 2 0.0000
94 TACHYCARDIA 1 0.0000
95 DEVICE ISSUE 1 0.0000
96 CARDIAC DISORDER 1 0.0000
97 CONTUSION 1 0.0000
98 ATRIAL FIBRILLATION 1 0.0000
99 SYNCOPE 1 0.0000
100 HYPOTENSION 2 0.0000
101 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
102 PLATELET COUNT DECREASED 1 0.0000
103 CONSTIPATION 2 0.0000
104 NAUSEA 7 0.0000
105 BACK PAIN 2 0.0000
106 LOSS OF CONSCIOUSNESS 1 0.0000
107 DRY SKIN 1 0.0000
108 PRODUCT QUALITY ISSUE 1 0.0000
109 VISION BLURRED 1 0.0000
110 WEIGHT DECREASED 2 0.0000
111 HYPOAESTHESIA 1 0.0000
112 ACUTE KIDNEY INJURY 1 0.0000
113 HOSPITALISATION 1 0.0000
114 PERIPHERAL SWELLING 1 0.0000
115 DIARRHOEA 4 0.0000
116 MYALGIA 1 0.0000
117 MYOCARDIAL INFARCTION 1 0.0000
118 HYPERSENSITIVITY 1 0.0000
119 SOMNOLENCE 1 0.0000
120 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
121 ABDOMINAL PAIN UPPER 1 0.0000
122 HYPERTENSION 1 0.0000
123 RASH 2 0.0000
124 MALAISE 2 0.0000
125 INCORRECT DOSE ADMINISTERED 1 0.0000
126 ABDOMINAL PAIN 1 0.0000
127 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
128 INSOMNIA 1 0.0000
129 INJECTION SITE PAIN 1 0.0000
130 HEADACHE 2 0.0000
131 FALL 1 0.0000
132 DRUG INEFFECTIVE 3 0.0000
133 DIZZINESS 1 0.0000
134 DYSPNOEA 1 0.0000
135 PAIN 1 0.0000
136 FATIGUE 1 0.0000
137 DEATH 1 0.0000
138 OFF LABEL USE 1 0.0000